Europe Medicine Agency (EMA)

Key Highlights Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity treatment, sold under Ozempic®, Wegovy®, and Rybelsus®.…

Summary : Pfizer Inc.   and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing…

Summary : ORGOVYX® is the first and only oral and rogend privation therapy for advanced hormone-sensitive prostate cancerin Europe Myovant expects to secure European…

Summary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC).…

In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance which had never been authorised…